STOCK TITAN
  1. Home
  2. CFRX

CFRX (CFRX) Stock Price, News & Analysis

CFRX NASDAQ

Company Description

CFRX (NASDAQ: CFRX) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for CFRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

Latest News

View All
-3.57%

ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development

conferences
+4.06%

ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370

clinical trial fda approval
+0.03%

ContraFect to Present at the World Anti-Microbial Resistance Congress 2023

conferences
-1.04%

ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update

earnings
+7.41%

ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million

-3.93%

ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens

CFRX has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, clinical trial, fda approval, earnings. View all CFRX news →

SEC Filings

View All

No SEC filings available for CFRX.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CFRX Company Profile & Sector Positioning

CFRX (CFRX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.